http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2291068-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-53
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
filingDate 1997-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02a02a19757b09826fc9edcc59ae2d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de096da3e6ed56ec31c64724e0083c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2056ed05d3a0e5bd850383cf0b086cf
publicationDate 1998-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2291068-A1
titleOfInvention Method for the preparation of citalopram
abstract A method for the preparation of citalopram is described comprising reduction of the oxo group of a compound of formula (IV), wherein R1 is CN, C1-6 alkyloxycarbonyl or C1-6 alkylaminocarbonyl, ring closure of the resulting hydroxy compound thereby obtaining the corresponding 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran, then if R1 is cyano using it directly in the next step and if R1 is C1-6 alkyloxycarbonyl or C1-6 alkylaminocarbonyl, conversion of the compound to the corresponding compound wherein R1 is cyano; and alkylation of the resulting 5-cyano compound with 3-dimethyl-aminopropylhalogenid in basic conditions thereby obtaining citalopram.
priorityDate 1997-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420010372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14230259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269

Total number of triples: 35.